Sustained increase of extracellular calcium concentration causes arterial vasoconstriction in humans

Journal of Hypertension

Volumn 23, Issue 11, 2005, Pages 2049-2054

  Scholze, Alexandra ^a   Maier, Alexandra ^a   Stocks, Franziska ^a   Karamohamad, Fadi ^a   Vetter, Roland ^a   Zidek, Walter ^a   Tepel, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Calcium; Sarcoendoplasmic reticulum Ca2+ ATPase activity; Vasoconstriction

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; CALCIUM OXALATE; FLUORESCENT DYE;

ADULT; AGED; ARTERY TONE; ARTICLE; BODY WEIGHT; CALCIUM BLOOD LEVEL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; COHORT ANALYSIS; CONTROLLED STUDY; DIALYSATE; ENZYME ACTIVITY; EXTRACELLULAR CALCIUM; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RADIAL ARTERY; SARCOPLASMIC RETICULUM; VASOCONSTRICTION; WAVEFORM;

EID: 29244474906     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000186831.41125.51     Document Type: Article

References (36)

1. Kesteloot H, Geboers J. Calcium and blood pressure. Lancet 1982; 1:813-815.
2. Jorde R, Sundsfjord J, Fitzgerald P, Bonaa KH. Serum calcium and cardiovascular risk factors and diseases: the Tromso study. Hypertension 1999; 34:484-490.
3. Kesteloot H, Joossens JV. Relationship of serum sodium, potassium, calcium, and phosphorus with blood pressure. Belgian interuniversity research on nutrition and health. Hypertension 1988; 12:589-593.
4. Williams PD, Puddey IB, Martin NG, Beilin LJ. Platelet cytosolic free calcium concentration, total plasma calcium concentration and blood pressure in human twins: a genetic analysis. Clin Sci 1992; 82:493-504.
5. Ellison DH, Shneidman R, Morris C, McCarron DA. Effects of calcium infusion on blood pressure in hypertensive and normotensive humans. Hypertension 1986; 8:497-505.
6. Imadojemu VA, Mooney K, Hogeman C, Lott MEJ, Kunselman A, Sinoway LI. Extracellular calcium and vascular responses after forearm ischemia. Circulation 2004; 110:79-83.
7. Carafoli E, Brini M. Calcium pumps: structural basis for and mechanism of calcium transmembrane transport. Curr Opin Chem Biol 2000; 4:152-161.
8. Launay S, Bobe R, Lacabaratz-Porret C, Bredoux R, Kovacs T, Enouf J, Papp B. Modulation of endoplasmic reticulum calcium pump expression during T lymphocyte activation. J Biol Chem 1997; 272:10746-10750.
9. Lytton J, Westlin M, Burk SE, Shull GE, MacLennan DH. Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. J Biol Chem 1999; 267:14483-14489.
10. 2+ ATPase inhibition. J Biol Chem 1998; 273:12994-12998.
11. Xu KY, Zweier JL, Becker LC. Hydroxyl radical inhibits sarcoplasmic reticulum Ca(2+)-ATPase function by direct attack on the ATP binding site. Circ Res 1997; 80:76-81.
12. Viner RI, Huhmer AF, Bigelow DJ, Schoneich C. The oxidative inactivation of sarcoplasmic reticulum Ca(2+)-ATPase by peroxynitrite. Free Radic Res 1997; 24:243-259.
13. Adachi T, Matsui R, Weisbrod RM, Najibi S, Cohen RA. Reduced sarco/ endoplasmic reticulum Ca(2+) uptake activity can account for the reduced response to NO, but not sodium nitroprusside, in hypercholesterolemic rabbit aorta. Circulation 2001; 104:1040-1045.
14. 2+ influx. Circ Res 1999; 84:210-219.
15. 3-exchange in patients with chronic renal failure: correlation with renal function. Kidney Int 1998; 53:432-438.
16. Garciandia A, Lopez R, Tisaire J, Arrazola A, Fortuno A, Bueno J, Diez J. Enhanced Na(+)-H+ exchanger activity and NHE-1 mRNA expression in lymphocytes from patients with essential hypertension. Hypertension 1995; 25:356-364.
17. Golik A, Weissgarten J, Evans S, Cohen N, Averbukh Z, Zaidenstein R, et al. Erythrocyte Na+, K+ and Ca2+, Mg(2+)-ATPase activities in hypertensives on angiotensin-converting enzyme inhibitors. Clin Biochem 1996; 29:249-254.
18. Dorffel Y, Latsch C, Stuhlmuller B, Schreiber S, Scholze S, Burmester GR, Scholze J. Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension 1999; 34:113-117.
19. Daugirdas JT. Second generation logarithmic estimates of variable volume single-pool Kt/V. J Am Soc Nephrol 1993; 4:1205-1212.
20. Rietzschel ER, Boeykens E, Boeykens E, De Buyzere ML, Duprez DA, Clement DL. A comparison between systolic and diastolic pulse contour analysis in the evaluation of arterial stiffness. Hypertension 2001; 37:E15-E22.
21. Finkelstein SM, Cohn JN. First- and third-order models for determining arterial compliance. J Hypertens 1992; 10:S11-S14.
22. McVeigh GE, Bratteli CW, Morgan DJ, Alinder CM, Glasser SP, Finkelstein SM, Cohn JN. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance. Hypertension 1999; 33:1392-1398.
23. Cohn JN, Finkelstein S, McVeigh G, Morgan D, LeMay L, Robinson J, Mock J. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension 1995; 26:503-508.
24. 2+ influx by atyrosine kinase-dependent pathway. J Biol Chem 1994; 269:26239-26242.
25. + exchange increases after an oral glucose challenge. Circ Res 1995; 77:1024-1029.
26. Tepel M, Wischniowski H, Zidek W. Erythropoietin induced transmembrane calcium influx in essential hypertension. Life Sci 1992; 51:161-167.
27. Vetter R, Rehfeld U, Reissfelder C, Weiss W, Wagner KD, Gunther J, et al. Transgenic overexpression of the sarcoplasmic reticulum Ca2+ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts. FASEB J 2002; 16:1657-1659.
28. Osol G, Halpern W. Myogenic properties of cerebral blood vessels from normotensive and hypertensive rats. Am J Physiol 1985; 249:H914-H921.
29. 2+-stores. Circ Res 1999; 84:201-209.
30. Nomura Y, Asano M, Ito K, Uyama Y, Imaizumi Y, Watanabe M. Potent vasoconstrictor actions of cyclopiazonic acid and thapsigargin on femoral arteries from spontaneously hypertensive rats. Br J Pharmacol 1997; 120:65-73.
31. 2+-channels. Eur J Pharmacol 1998; 341:343-347.
32. Mosior M, Epand RM. Characterization of the calcium-binding site that regulates association of protein kinase C with phospholipid bilayers. J Biol Chem 1994; 269:13798-13805.
33. Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem 1995; 270:28495-28498.
34. Barton IK, Mansell MA, Grimes AJ. Red-cell calcium in patients with renal failure. Nephron 1987; 47:123-124.
35. Colyer J. Phosphorylation states of phospholamban. Ann NY Acad Sci 1998; 853:79-91.
36. MacLennan DH, Kranias EG. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 2003; 4:566-577.